OnKure Therapeutics, Inc. (OKUR) — Financial Flexibility Index
OnKure Therapeutics, Inc. (OKUR) has a Financial Flexibility Index of -1.43x as of June 2026. Free cash flow of $-10.35 Million (operating CF $-10.35 Million minus capex $3.00K) represents -1% of total liabilities ($7.25 Million). Check OnKure Therapeutics, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OnKure Therapeutics, Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for OnKure Therapeutics, Inc. across 6 annual periods. For the full cash flow conversion analysis, see OnKure Therapeutics, Inc. (OKUR) cash flow conversion.
Annual Financial Flexibility Index for OnKure Therapeutics, Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for OnKure Therapeutics, Inc.. Explore cash flow to debt ratio of OnKure Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -8.73x | $-51.78 Million | $-51.83 Million | $5.93 Million | ▼ -89.4% |
| 2024 | -4.61x | $-51.06 Million | $-51.12 Million | $11.08 Million | ▼ -1748.7% |
| 2023 | -0.25x | $-34.30 Million | $-34.55 Million | $137.58 Million | ▲ +32.0% |
| 2022 | -0.37x | $-25.82 Million | $-26.95 Million | $70.42 Million | ▲ +93.4% |
| 2021 | -5.55x | $-37.78 Million | $-37.98 Million | $6.81 Million | ▼ -2816.1% |
| 2020 | -0.19x | $-18.51 Million | $-18.54 Million | $97.34 Million | — |